146 related articles for article (PubMed ID: 22903864)
1. Polymyositis after donor lymphocyte infusion.
Montoro J; Hernández-Boluda JC; Arbona C; Solano C
Int J Hematol; 2012 Sep; 96(3):386-9. PubMed ID: 22903864
[TBL] [Abstract][Full Text] [Related]
2. Acute polymyositis after donor lymphocyte infusion.
Lin PC; Hsiao LT; Chen PM
Eur J Haematol; 2005 Feb; 74(2):166-8. PubMed ID: 15654909
[TBL] [Abstract][Full Text] [Related]
3. Polymyositis and myocarditis after donor lymphocyte infusion.
Ahn JS; Cho SH; Kim YK; Yang DH; Bae WK; Shim HJ; Lee JJ; Chung IJ; Juhng SW; Kim HJ
Int J Hematol; 2009 Jul; 90(1):113-116. PubMed ID: 19472035
[TBL] [Abstract][Full Text] [Related]
4. Relapsing polymyositis in chronic graft versus host disease.
Sharaf N; Prayson RA
J Clin Neurosci; 2014 Nov; 21(11):1964-5. PubMed ID: 24980629
[TBL] [Abstract][Full Text] [Related]
5. Polymyositis complicating donor lymphocyte infusion after stem cell transplantation for relapsed chronic myeloid leukemia: report of a case and review of literature.
Liu FC; Chen CH; Chao TY
Clin Rheumatol; 2007 Jul; 26(7):1207-10. PubMed ID: 16937070
[TBL] [Abstract][Full Text] [Related]
6. Liver graft-versus-host disease after donor lymphocyte infusion for relapses of hematologic malignancies post allogeneic hematopoietic stem cell transplantation.
Ma SY; Au WY; Lie AK; Ng IO; Leung AY; Tse EW; Liang RH; Lau GK; Kwong YL
Bone Marrow Transplant; 2004 Jul; 34(1):57-61. PubMed ID: 15156162
[TBL] [Abstract][Full Text] [Related]
7. Alpha-interferon with very-low-dose donor lymphocyte infusion for hematologic or cytogenetic relapse of chronic myeloid leukemia induces rapid and durable complete remissions and is associated with acceptable graft-versus-host disease.
Posthuma EF; Marijt EW; Barge RM; van Soest RA; Baas IO; Starrenburg CW; van Zelderen-Bhola SL; Fibbe WE; Smit WM; Willemze R; Falkenburg JH
Biol Blood Marrow Transplant; 2004 Mar; 10(3):204-12. PubMed ID: 14993886
[TBL] [Abstract][Full Text] [Related]
8. Myositis, polyserositis with a large pericardial effusion and constrictive pericarditis as manifestations of chronic graft-versus-host disease after non-myeloablative peripheral stem cell transplantation and subsequent donor lymphocyte infusion.
Silberstein L; Davies A; Kelsey S; Foran J; Murrell C; D'Cruz D; Vinnicombe S; Norton A; Cavenagh J
Bone Marrow Transplant; 2001 Jan; 27(2):231-3. PubMed ID: 11281399
[TBL] [Abstract][Full Text] [Related]
9. [Chronic GVHD with polymyositis after non-myeloablative stem cell transplantation].
Nakamae H; Himuro K; Hagihara K; Terada Y; Sakamoto E; Takeoka Y; Nakane T; Nakamae M; Ohta K; Yamane T; Shimada H; Miki T; Hino M
Rinsho Ketsueki; 2005 Nov; 46(11):1213-7. PubMed ID: 16440806
[TBL] [Abstract][Full Text] [Related]
10. Low-dose methotrexate may preserve a stronger antileukemic effect than that of cyclosporine after modified donor lymphocyte infusion in unmanipulated haploidentical HSCT.
Yan CH; Xu LP; Liu DH; Chen H; Wang Y; Wang JZ; Wang FR; Han W; Liu KY; Huang XJ
Clin Transplant; 2015 Jul; 29(7):594-605. PubMed ID: 25969866
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the safety and efficacy of prophylactic donor lymphocyte infusion after haploidentical versus matched-sibling PBSCT in very high-risk acute myeloid leukemia.
Gao XN; Lin J; Wang LJ; Li F; Li HH; Wang SH; Huang WR; Gao CJ; Yu L; Liu DH
Ann Hematol; 2019 May; 98(5):1267-1277. PubMed ID: 30747249
[TBL] [Abstract][Full Text] [Related]
12. Prophylactic Donor Lymphocyte Infusion (DLI) Followed by Minimal Residual Disease and Graft-versus-Host Disease-Guided Multiple DLIs Could Improve Outcomes after Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Refractory/Relapsed Acute Leukemia.
Yan CH; Liu QF; Wu DP; Zhang X; Xu LP; Zhang XH; Wang Y; Huang H; Bai H; Huang F; Ma X; Huang XJ
Biol Blood Marrow Transplant; 2017 Aug; 23(8):1311-1319. PubMed ID: 28483716
[TBL] [Abstract][Full Text] [Related]
13. Herpes simplex thymidine kinase gene-transduced donor lymphocyte infusions.
Burt RK; Drobyski WR; Seregina T; Traynor A; Oyama Y; Keever-Taylor C; Stefka J; Kuzel TM; Brush M; Rodriquez J; Burns W; Tennant L; Link C
Exp Hematol; 2003 Oct; 31(10):903-10. PubMed ID: 14550806
[TBL] [Abstract][Full Text] [Related]
14. Donor Lymphocyte Infusions for Chronic Myeloid Leukemia Relapsing after Allogeneic Stem Cell Transplantation: May We Predict Graft-versus-Leukemia Without Graft-versus-Host Disease?
Radujkovic A; Guglielmi C; Bergantini S; Iacobelli S; van Biezen A; Milojkovic D; Gratwohl A; Schattenberg AV; Verdonck LF; Niederwieser DW; de Witte T; Kröger N; Olavarria E;
Biol Blood Marrow Transplant; 2015 Jul; 21(7):1230-6. PubMed ID: 25797175
[TBL] [Abstract][Full Text] [Related]
15. Chronic graft-versus-host disease presenting as acute polymyositis: A case series and systematic review.
Shahzad M; Chaudhary SG; Basit A; Thellman C; Rodriguez L; Abhyankar SH; McGuirk JP; Mushtaq MU
Transpl Immunol; 2022 Feb; 70():101520. PubMed ID: 34952168
[TBL] [Abstract][Full Text] [Related]
16. Chronic graft-versus-host disease manifesting as polymyositis: an uncommon presentation.
Couriel DR; Beguelin GZ; Giralt S; De Lima M; Hosing C; Kharfan-Dabaja MA; Anagnostopoulos A; Champlin R
Bone Marrow Transplant; 2002 Oct; 30(8):543-6. PubMed ID: 12379897
[TBL] [Abstract][Full Text] [Related]
17. Graft-versus-lymphoma effect of donor lymphocyte infusion in indolent lymphomas relapsed after allogeneic stem cell transplantation.
Mandigers CM; Verdonck LF; Meijerink JP; Dekker AW; Schattenberg AV; Raemaekers JM
Bone Marrow Transplant; 2003 Dec; 32(12):1159-63. PubMed ID: 14647270
[TBL] [Abstract][Full Text] [Related]
18. Modified donor lymphocyte infusion-associated acute graft-versus-host disease after haploidentical T-cell-replete hematopoietic stem cell transplantation: incidence and risk factors.
Yan CH; Liu DH; Xu LP; Liu KY; Zhao T; Wang Y; Chen H; Chen YH; Han W; Huang XJ
Clin Transplant; 2012; 26(6):868-76. PubMed ID: 22432715
[TBL] [Abstract][Full Text] [Related]
19. Comparison of outcomes after donor lymphocyte infusion with or without prior chemotherapy for minimal residual disease in acute leukemia/myelodysplastic syndrome after allogeneic hematopoietic stem cell transplantation.
Mo XD; Zhang XH; Xu LP; Wang Y; Yan CH; Chen H; Chen YH; Han W; Wang FR; Wang JZ; Liu KY; Huang XJ
Ann Hematol; 2017 May; 96(5):829-838. PubMed ID: 28285386
[TBL] [Abstract][Full Text] [Related]
20. Clinical evidence of a graft-versus-Hodgkin's-lymphoma effect after reduced-intensity allogeneic transplantation.
Peggs KS; Hunter A; Chopra R; Parker A; Mahendra P; Milligan D; Craddock C; Pettengell R; Dogan A; Thomson KJ; Morris EC; Hale G; Waldmann H; Goldstone AH; Linch DC; Mackinnon S
Lancet; 2005 Jun 4-10; 365(9475):1934-41. PubMed ID: 15936420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
